NSCI.V - Nanalysis Scientific Corp.

TSXV - TSXV Real Time Price. Currency in CAD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
22,707
24,821
16,043
7,874
8,364
Cost of Revenue
10,115
13,682
5,803
2,707
2,304
Gross Profit
12,592
11,139
10,240
5,167
6,060
Operating Expenses
Research Development
1,338
1,465
643
476
-
Selling General and Administrative
13,463
15,020
8,283
6,751
5,219
Total Operating Expenses
18,752
21,049
11,431
8,908
5,994
Operating Income or Loss
-6,160
-9,910
-1,191
-3,741
66
Total Other Income/Expenses Net
-863
-413
-583
-562
-1,524
Income Before Tax
-7,305
-10,399
-1,772
-3,975
-1,399
Income Tax Expense
-37
-484
0
-297
261
Income from Continuing Operations
-7,268
-9,915
-1,772
-3,678
-1,660
Net Income
-6,856
-9,915
-1,772
-3,678
-1,660
Net Income available to common shareholders
-6,856
-9,915
-1,772
-3,678
-1,660
Basic EPS
-
-0.10
-0.03
-0.06
-0.03
Diluted EPS
-
-0.10
-0.03
-0.06
-0.03
Basic Average Shares
-
92,476
70,402
65,324
55,632
Diluted Average Shares
-
92,476
70,402
65,324
55,632
EBITDA
-
-5,261
1,376
-1,971
911